Holen Sie sich die Stockscreener-App
1.07
4.46%
-0.05
Handel nachbörslich:
1.05
-0.02
-1.87%
Schlusskurs vom Vortag:
$1.12
Offen:
$1.13
24-Stunden-Volumen:
134.27K
Relative Volume:
0.47
Marktkapitalisierung:
$36.57M
Einnahmen:
$98.92M
Nettoeinkommen (Verlust:
$-1.24M
KGV:
-17.83
EPS:
-0.06
Netto-Cashflow:
$2.64M
1W Leistung:
-2.73%
1M Leistung:
+28.93%
6M Leistung:
-51.36%
1J Leistung:
-42.16%
1-Tages-Spanne:
$1.0499
$1.15
1-Wochen-Bereich:
$1.0499
$1.18
52-Wochen-Spanne:
$0.7801
$5.15
Rockwell Medical Inc Stock (RMTI) Company Profile
Firmenname
Rockwell Medical Inc
Sektor
Telefon
(800) 449-3353
Adresse
30142 WIXOM ROAD, WIXOM, NJ
Vergleichen Sie RMTI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RMTI
Rockwell Medical Inc
|
1.07 | 38.37M | 98.92M | -1.24M | 2.64M | -0.06 |
|
ZTS
Zoetis Inc
|
152.12 | 68.04B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.48 | 46.30B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.88 | 44.25B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.54 | 18.73B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
304.50 | 13.82B | 2.99B | 1.21B | 1.13B | 25.06 |
Rockwell Medical Inc Stock (RMTI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-14 | Eingeleitet | Rodman & Renshaw | Buy |
| 2019-06-24 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-05-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-11-08 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2016-03-01 | Herabstufung | Stifel | Buy → Hold |
| 2015-08-13 | Eingeleitet | Morgan Stanley | Underweight |
| 2015-01-27 | Bestätigt | Oppenheimer | Outperform |
| 2015-01-07 | Eingeleitet | Oppenheimer | Outperform |
| 2014-08-14 | Eingeleitet | FBR Capital | Underperform |
| 2013-12-19 | Eingeleitet | Chardan Capital Markets | Buy |
| 2013-11-06 | Bestätigt | Summer Street Research | Buy |
| 2013-09-05 | Bestätigt | Summer Street Research | Buy |
| 2013-08-02 | Bestätigt | Summer Street Research | Buy |
| 2012-04-11 | Eingeleitet | Summer Street Research | Buy |
| 2012-03-12 | Eingeleitet | Stifel Nicolaus | Buy |
| 2012-01-03 | Eingeleitet | Canaccord Genuity | Buy |
| 2009-12-10 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2009-10-12 | Eingeleitet | Wedbush Morgan | Outperform |
Alle ansehen
Rockwell Medical Inc Aktie (RMTI) Neueste Nachrichten
Rockwell Medical, Innovative Renal Care Partner on Hemodialysis Product Continuity - Medical Product Outsourcing
Will Rockwell Medical Inc. stock benefit from interest rate changesPhenomenal wealth increase - jammulinksnews.com
What drives Rockwell Medical Inc. stock priceMarket-leading capital gains - Autocar Professional
Rockwell Medical Inc. Stock Analysis and ForecastRapid return acceleration - Autocar Professional
Is Rockwell Medical Inc. a good long term investmentAccelerated earnings growth - Autocar Professional
Hemodialysis Therapy Market is projected to grow to USD 19.81 - openPR.com
What analysts say about Rockwell Medical Inc. stockUnstoppable profit momentum - jammulinksnews.com
Why Rockwell Medical Inc. stock attracts strong analyst attentionLow Risk High Reward Picks - Newser
Rockwell Medical to Release Second Quarter 2025 Results on Thursday, August 14, 2025 - Business Wire
META_TITLE_SECTORS - Yahoo Finance
What makes Rockwell Medical Inc. stock price move sharplyFree Stock Movement Tracking - Newser
How Rockwell Medical Inc. stock performs during market volatilityFree Consultation - Newser
RMTI’s Stock Market Adventure: -38.25% YTD Growth Amidst Volatility - investchronicle.com
Healthcare Stocks to Watch: Evaxion Biotech, CVRx, and Rockwell Medical Receive Bullish Sentiments - AInvest
Rockwell Medical, Inc. (NASDAQ:RMTI) Held Back By Insufficient Growth Even After Shares Climb 25% - simplywall.st
Rockwell Medical Soars 13.45% on Strategic Partnership - AInvest
Rockwell Medical's Strategic Initiatives and Market Positioning Support Buy Rating with $3 Price Target - AInvest
Rockwell Medical signs multi-year supply agreement with Innovative Renal Care - Investing.com Nigeria
Rockwell Medical and Innovative Renal Care Announce Three-Year Partnership Agreement to Ensure Supply Chain Continuity of Quality Hemodialysis Products - MarketScreener
Rockwell Medical signs multi-year supply agreement with Innovative Renal Care By Investing.com - Investing.com South Africa
Rockwell Medical, Inc.(NasdaqCM: RMTI) added to Russell Microcap Value Index - MarketScreener
Iron Deficiency Anemia Market Trends: Rising Demand for IV Iron - openPR.com
Intravenous Iron Drugs Market to Reach USD 6.63 Bn by 2032 - newstrail.com
Rockwell Medical (NASDAQ:RMTI) Raised to Hold at Wall Street Zen - Defense World
Millennium Management LLC Cuts Position in Rockwell Medical, Inc. (NASDAQ:RMTI) - Defense World
RMTIRockwell Medical Announces First Quarter 2025 Results - Revista ADVFN
Dialysis Equipment Market to Reach $191.24 Bn by 2032 - newstrail.com
Key Market Driver in intravenous iron drugs Industry 2025: RisinNORTHEAST - NORTHEAST - NEWS CHANNEL NEBRASKA
Iron Deficiency Anemia Market Accelerates with Health Programs - openPR.com
Rockwell Medical (NASDAQ:RMTI) Downgraded to “Sell” Rating by Wall Street Zen - Defense World
Dialysate Market Insights: Growing at 6.04% CAGR to USD 9.8 Billion by 2031 - openPR.com
HC Wainwright Issues Pessimistic Estimate for RMTI Earnings - Defense World
Finanzdaten der Rockwell Medical Inc-Aktie (RMTI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Rockwell Medical Inc-Aktie (RMTI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Neri Jesse | SVP and CFO |
Jul 01 '25 |
Sale |
0.82 |
886 |
727 |
126,614 |
| Strobeck Mark | President and CEO |
Jul 01 '25 |
Sale |
0.82 |
6,926 |
5,679 |
337,752 |
2.82%
0.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):